RJ Stephens

3.3k total citations · 1 hit paper
43 papers, 2.4k citations indexed

About

RJ Stephens is a scholar working on Pulmonary and Respiratory Medicine, Oncology and Epidemiology. According to data from OpenAlex, RJ Stephens has authored 43 papers receiving a total of 2.4k indexed citations (citations by other indexed papers that have themselves been cited), including 22 papers in Pulmonary and Respiratory Medicine, 21 papers in Oncology and 6 papers in Epidemiology. Recurrent topics in RJ Stephens's work include Lung Cancer Treatments and Mutations (16 papers), Lung Cancer Research Studies (13 papers) and Lung Cancer Diagnosis and Treatment (13 papers). RJ Stephens is often cited by papers focused on Lung Cancer Treatments and Mutations (16 papers), Lung Cancer Research Studies (13 papers) and Lung Cancer Diagnosis and Treatment (13 papers). RJ Stephens collaborates with scholars based in United Kingdom, United States and Belgium. RJ Stephens's co-authors include DJ Girling, David Machin, Penelope Hopwood, NM Bleehen, Lesley Stewart, R L Souhami, Sarah Burdett, Jean‐Pierre Pignon, R. Arriagada and P Rocmans and has published in prestigious journals such as The Lancet, Journal of Clinical Oncology and British Journal of Cancer.

In The Last Decade

RJ Stephens

43 papers receiving 2.3k citations

Hit Papers

Postoperative radiotherapy in non-small-cell lung cancer:... 1998 2026 2007 2016 1998 100 200 300 400 500

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
RJ Stephens United Kingdom 21 1.6k 1.2k 281 245 189 43 2.4k
Franz M.N.H. Schramel Netherlands 25 2.3k 1.4× 1.3k 1.1× 302 1.1× 449 1.8× 101 0.5× 110 2.9k
Roldano Fossati Italy 18 1.7k 1.1× 1.7k 1.4× 304 1.1× 418 1.7× 88 0.5× 49 3.5k
D. Ian Hodson Canada 21 1.2k 0.7× 862 0.7× 166 0.6× 589 2.4× 98 0.5× 38 2.1k
Oscar Bertetto Italy 26 639 0.4× 1.2k 1.0× 137 0.5× 561 2.3× 160 0.8× 105 2.3k
Stefan Bergström Sweden 22 472 0.3× 492 0.4× 130 0.5× 218 0.9× 154 0.8× 79 1.4k
Athanasios Pallis Greece 31 1.1k 0.7× 1.5k 1.2× 144 0.5× 265 1.1× 197 1.0× 103 2.7k
Peter Skingley Canada 10 686 0.4× 703 0.6× 81 0.3× 273 1.1× 88 0.5× 14 1.4k
Brent S. Rose United States 28 1.2k 0.7× 807 0.7× 424 1.5× 766 3.1× 139 0.7× 171 2.6k
Leslie J. Kohman United States 32 2.6k 1.6× 846 0.7× 441 1.6× 783 3.2× 38 0.2× 74 3.4k
Peter Kirkbride Canada 18 621 0.4× 530 0.4× 150 0.5× 793 3.2× 88 0.5× 33 1.8k

Countries citing papers authored by RJ Stephens

Since Specialization
Citations

This map shows the geographic impact of RJ Stephens's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by RJ Stephens with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites RJ Stephens more than expected).

Fields of papers citing papers by RJ Stephens

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by RJ Stephens. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by RJ Stephens. The network helps show where RJ Stephens may publish in the future.

Co-authorship network of co-authors of RJ Stephens

This figure shows the co-authorship network connecting the top 25 collaborators of RJ Stephens. A scholar is included among the top collaborators of RJ Stephens based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with RJ Stephens. RJ Stephens is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Burdett, Sarah, RJ Stephens, Lesley Stewart, et al.. (2008). Chemotherapy in addition to supportive care improves survival in advanced non-small-cell lung cancer: A systematic review and meta-analysis of individual patient data from 16 randomized controlled trials - NSCLC meta-analyses collaborative group. Journal of Clinical Oncology. 26(28). 4617–4625. 165 indexed citations
2.
Plessen, Christian von, Bengt Bergman, R. M. Bremnes, et al.. (2006). Palliative chemotherapy beyond three courses conveys no survival or consistent quality-of-life benefits in advanced non-small-cell lung cancer. British Journal of Cancer. 95(8). 966–973. 124 indexed citations
4.
Martin, Jarad, et al.. (2005). Managing waiting time for radiotherapy: A single machine unit experience. Australasian Radiology. 49(6). 480–484. 4 indexed citations
5.
Stephens, RJ, Julia Brown, N.H. Gower, et al.. (2002). The big lung trial (BLT): Determining the value of cisplatin- based chemotherapy for all patients with non-small cell lung cancer (NSCLC). Preliminary results in the supportive care setting. UCL Discovery (University College London). 43 indexed citations
6.
Ledermann, JA, T.S. Maughan, Daniel Kerr, et al.. (1999). Preliminary results of a multicentre randomised trial comparing 3 chemotherapy regimens (De Gramont, Lokich and Raltitrexed) in metastatic colorectal cancer. UCL Discovery (University College London). 41 indexed citations
7.
Julious, Steven A., S. George, David Machin, & RJ Stephens. (1997). Sample sizes for randomized trials measuring quality of life in cancer patients. Quality of Life Research. 6(2). 109–117. 18 indexed citations
8.
Feld, Ronald, Raymond P. Abratt, Stephen L. Graziano, et al.. (1997). Pretreatment minimal staging and prognostic factors for non-small cell lung cancer. Lung Cancer. 17. S3–S10. 35 indexed citations
9.
Machin, David, Sally Stenning, Mahesh Parmar, et al.. (1997). Thirty years of medical research council randomized trials in solid tumours. Clinical Oncology. 9(2). 100–114. 43 indexed citations
11.
Gregor, A., A. Cull, RJ Stephens, Fergus Macbeth, & N. Thatcher. (1995). 87 Effects of prophylactic cranial irradiation (PCI) in small cell lung cancer (SCLC); results of UKCCCR/EORTC randomised trial. European Journal of Cancer. 31. S20–S20. 5 indexed citations
12.
Hopwood, Penelope & RJ Stephens. (1995). Symptoms at presentation for treatment in patients with lung cancer: implications for the evaluation of palliative treatment. British Journal of Cancer. 71(3). 633–636. 155 indexed citations
13.
Bleehen, N M, DJ Girling, A. Gregor, et al.. (1994). Can long-term survival be improved in patients with small-cell lung cancer (SCLC) and good performance status?. British Journal of Cancer. 70(1). 142–144. 1 indexed citations
14.
Bleehen, NM, DJ Girling, David Machin, & RJ Stephens. (1993). A randomised trial of three or six courses of etoposide cyclophosphamide methotrexate and vincristine or six courses of etoposide and ifosfamide in small cell lung cancer (SCLC). II: Quality of life. British Journal of Cancer. 68(6). 1157–1166. 59 indexed citations
15.
Whitehead, John, et al.. (1993). A simulated sequential analysis based on data from two MRC trials. British Journal of Cancer. 68(6). 1171–1178. 8 indexed citations
17.
Stephens, RJ, et al.. (1993). The impact of clinical trials on the treatment of lung cancer. Clinical Oncology. 5(4). 211–219. 25 indexed citations
19.
Bleehen, NM, DJ Girling, A. Gregor, et al.. (1991). A Medical Research Council phase II trial of alternating chemotherapy and radiotherapy in small-cell lung cancer. British Journal of Cancer. 64(4). 775–779. 10 indexed citations
20.
Stott, H, Wallace Fox, D.J. Girling, RJ Stephens, & D. A. G. Galton. (1977). Acute leukaemia after busulphan.. BMJ. 2(6101). 1513–1517. 58 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026